Inventor · disambiguated record
David Cavalla
Also filed as: CAVALLA DAVID · CAVALLA DAVID J · CAVALLA DAVID JOHN
44 granted patents·12 pending applications·599 citations·filing 1988–2022
98Inventor score
Top patents by PatentIndex Score
56 records- 0191US6166041A2-heteroaryl and 2-heterocyclic benzoxazoles as PDE IV inhibitors for the treatment of asthmaEURO CELTIQUE SA·Filed 1997·Granted Dec 26, 2000·85 cites·11 claims
- 0289US6248769B1Phenyl-triazole compounds for PDE-IV inhibitionEURO CELTIQUE SA·Filed 2000·Granted Jun 19, 2001·22 cites·23 claims
- 0389US4808581AImidazolyl- indolylpropanones as 5-HT3 receptor antagonistsGLAXO GROUP LTD·Filed 1988·Granted Feb 28, 1989·28 cites·23 claims
- 0488US5922751AAryl pyrazole compound for inhibiting phosphodiesterase IV and methods of using sameEURO CELTIQUE SA·Filed 1997·Granted Jul 13, 1999·40 cites·24 claims
- 0580US6413975B1Purine derivatives having phosphodiesterase iv inhibition activityEURO CELTIQUE SA·Filed 2000·Granted Jul 2, 2002·17 cites·11 claims
- 0680US5864037AMethods for the synthesis of chemical compounds having PDE-IV inhibitory activityEURO CELTIQUE SA·Filed 1996·Granted Jan 26, 1999·46 cites·18 claims
- 0779US6319928B1Purine derivatives having phosphodiesterase IV inhibition activityEURO CELTIQUE SA·Filed 1999·Granted Nov 20, 2001·27 cites·50 claims
- 0879US6228859B1Purine derivatives having phosphodiesterase IV inhibition activityEURO CELTIQUE SA·Filed 1998·Granted May 8, 2001·32 cites·35 claims
- 0976US5591776APheynl or benzyl-substituted rolipram-based compounds for and method of inhibiting phosphodiesterase IVEURO CELTIQUE SA·Filed 1995·Granted Jan 7, 1997·31 cites·15 claims
- 1074US7220748B2Use of 4-(2-Flurophenyl)-6-methyl-2-(1-piperazinyl)thieno(2,3-D)-pyrimidine for treating of urinary incontinenceARACHNOVA THERAPEUTICS LTD·Filed 2003·Granted May 22, 2007·7 cites·3 claims
- 1173US5744473APDE IV inhibitors: "bis-compounds"EURO CELTIQUE SA·Filed 1996·Granted Apr 28, 1998·16 cites·17 claims
- 1271US6211367B1Methods of Synthesing Purine Compounds Having PDE Iv Inhibitory ActivityEURO CELTIQUE SA·Filed 1998·Granted Apr 3, 2001·23 cites·12 claims
- 1369US9487492B2Dibenzothiazepine derivatives and their use in the treatment of CNS disordersCAVALLA DAVID·Filed 2012·Granted Nov 8, 2016·2 cites·30 claims
- 1469US6103749AAryl imidazole compounds having phosphodiesterase IV inhibitory activityEURO CELTIQUE SA·Filed 1999·Granted Aug 15, 2000·11 cites·19 claims
- 1569US6066641AAryl thioxanthinesEURO CELTIQUE SA·Filed 1995·Granted May 23, 2000·21 cites·13 claims
- 1668US2022265676A1Tricyclic dibenzothiazepine type compounds for use in the therapy of cdkl5 disorderHEALX LTD·Filed 2021·Application pending·0 cites
- 1767US6153630APhenylpyridyl compounds for inhibiting phosphodiesterase IV and methods of using sameEURO CELTIQUE SA·Filed 1996·Granted Nov 28, 2000·20 cites·20 claims
- 1865US5889014AHeterocyclic compounds for inhibiting phosphodiesterase IVEURO CELTIQUE SA·Filed 1996·Granted Mar 30, 1999·17 cites·16 claims
- 1964US6040447APurine compounds having PDE IV inhibitory activity and methods of synthesisEURO CELTIQUE SA·Filed 1998·Granted Mar 21, 2000·13 cites·12 claims
- 2064US5026722AIndole derivativesGLAXO GROUP LTD·Filed 1989·Granted Jun 25, 1991·6 cites·10 claims
- 2162US6057445APurine compounds having PDE IV inhibitory activity and methods of synthesisEURO CELTIQUE SA·Filed 1998·Granted May 2, 2000·12 cites·19 claims
- 2262US6037470APurine compounds having PDE IV inhibitory activity and methods of synthesisEURO CELTIQUE SA·Filed 1998·Granted Mar 14, 2000·12 cites·15 claims
- 2362US5939422AChemical compounds having PDE-IV inhibition activityEURO CELTIQUE SA·Filed 1994·Granted Aug 17, 1999·21 cites·50 claims
- 2461US6025361ATrisubstituted thioxanthinesEURO CELTIQUE SA·Filed 1995·Granted Feb 15, 2000·16 cites·10 claims
- 2560US6075016A6,5-fused aromatic ring systems having enhanced phosphodiesterase IV inhibitory activityEURO CELTIQUE SA·Filed 1997·Granted Jun 13, 2000·7 cites·8 claims
- 2660US4963546AKetone derivatives which are antagonists of 5-HT at 5-HT3 receptors, compositions containing them, and method of useGLAXO GROUP LTD·Filed 1989·Granted Oct 16, 1990·4 cites·9 claims
- 2759US7470690B24-(2-Fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno[2,3-D)pyrimidine in the treatment of functional bowel disorderDYNOGEN PHARMACEUTICALS INC·Filed 2003·Granted Dec 30, 2008·0 cites·3 claims
- 2859US6310205B1Hypoxathine compoundsEURO CELTIQUE SA·Filed 1999·Granted Oct 30, 2001·13 cites·13 claims
- 2958US6294541B1Purine derivatives having phosphodiesterase IV inhibition activityEURO CELTIQUE SA·Filed 1999·Granted Sep 25, 2001·15 cites·43 claims
- 3058US2004048874A1New therapeutic use of 4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno[2,3-D]pyrimidineFiled 2003·Application pending·0 cites
- 3158US2009215791A1New therapeutic use of 4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno[2,3-d]pyrimidineDYNOGEN PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 3257US2018271876A1Tricyclic dibenzothiazepine type compounds for use in the therapy of cdkl5 disorderHEALX LTD·Filed 2016·Application pending·0 cites
- 3355US2019381065A1Tricyclic dibenzothiazepine type compounds for use in the therapy of cdkl5 disorderHEALX LTD·Filed 2019·Application pending·0 cites
- 3454US8716325B2Treatment of cachexiaCAVALLA DAVID·Filed 2007·Granted May 6, 2014·0 cites·16 claims
- 3554US2023330080A1Therapeutic treatment using protein kinase c (pkc) inhibitors and cytotoxic agentsCAMBRIDGE ENTPR LTD·Filed 2021·Application pending·0 cites
- 3653US6372770B1BenzoxazolesEURO CELTIQUE SA·Filed 1998·Granted Apr 16, 2002·10 cites·46 claims
- 3752US6440979B1Aryl isoguaninesEURO CELTIQUE SA·Filed 2000·Granted Aug 27, 2002·0 cites·16 claims
- 3852US6268373B1Trisubstituted thioxanthinesEURO CELTIQUE SA·Filed 1999·Granted Jul 31, 2001·4 cites·13 claims
- 3951US4950681AKetone derivativesGLAXO GROUP LTD·Filed 1988·Granted Aug 21, 1990·5 cites·10 claims
- 4050US11752152B1Pharmaceutical formulations of imatinib and uses thereofEXVASTAT LTD·Filed 2022·Granted Sep 12, 2023·0 cites·18 claims
- 4150US6248746B13-(arylalkyl) xanthinesEURO CELTIQUE SA·Filed 1999·Granted Jun 19, 2001·8 cites·13 claims
- 4246US6365606B16,5-fused aromatic ring systems having enhanced phosphodiesterase IV inhibitory activityEURO CELTIQUE SA·Filed 2000·Granted Apr 2, 2002·0 cites·9 claims
- 4342US4918080AImidazollyl containing ketone derivativesGLAXO GROUP LTD·Filed 1988·Granted Apr 17, 1990·2 cites·8 claims
- 4442US2006088556A1Topical formulation and use of buspironeCAVALLA DAVID·Filed 2004·Application pending·0 cites
- 4542US2004242547A1Arylazo-substituted imidazole for the treatment of stress urinary incontinenceFiled 2002·Application pending·0 cites
- 4642US2006013775A1Use of ppar activators for the treatment of pulmonary fibrosisGRISTWOOD ROBERT W·Filed 2002·Application pending·0 cites
- 4741US5006544AImidazole derivatives and pharmaceutical use thereofGLAXO GROUP LTD·Filed 1989·Granted Apr 9, 1991·3 cites·9 claims
- 4841US2006167005A1New therapeutic uses of (4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl) thieno [2,3-d] pyrimidineCAVALLA DAVID·Filed 2003·Application pending·0 cites
- 4940US5026696AKetone derivatives which are antagonists of 5-HT at 5-HT3 receptors, compositions containing them, and method of useGLAXO GROUP LTD·Filed 1990·Granted Jun 25, 1991·1 cites·7 claims
- 5040US2003073834A1Purine compounds having PDE IV inhibitory activity and methods of synthesisFiled 2002·Application pending·0 cites
Showing the top 50 of 56 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →